Solara Active Pharma Rights Issue Date, Price, Allotment, Entitlement

0

Last updated on May 14, 2024

Solara Active Pharma Rights Issue

Solara Active Pharma Rights Issue is scheduled on 28 May – 11 June 2024

Solara Active Pharma Sciences is a global company focused on research and development, specializing in the production and development of Active Pharmaceutical Ingredients (APIs). It also provides Contract Manufacturing and Development Services for international companies. Solara Active Pharma Sciences is involved in the business of manufacturing, production, processing, formulation, sale, import, export, merchandising, distribution, and trading of Active Pharmaceutical Ingredients (APIs).

The company operates six large-scale multi-product facilities that adhere to high compliance standards, supported by a team of over 2,300 employees. Its business spans 75 countries, with significant operations in key markets such as North America, Europe, Japan, South Korea, and the Middle East and North Africa.

As of February 2024, the company offers over 60 commercial Active Pharmaceutical Ingredients (APIs), with an additional 10 APIs currently in development.

Solara Active Pharma Sciences Rights Issue

Promoters of Solara Active Pharma –


Solara Active Pharma Rights Issue Details

Solara Active Pharma Rights Issue Date28 May – 11 June 2024
Solara Active Pharma Rights Issue PriceINR 375 per share
Issue Size (in Shares)1,19,98,755 shares
Issue Size (in INR)INR 449.95 crore
Issue Entitlement1 equity shares for every 3 equity shares held on record date
Terms of PaymentPartly paid-up Equity Shares; In three calls i.e. 35% on the application; 35% on the first call and 30% on the final call.
Rights Issue Record Date15 May 2024
Face ValueINR 10 per share
Listing OnBSE, NSE

Solara Active Pharma Rights Issue Calculation

Solara Active Pharma Rights Issue PriceINR 375 per share
Market Price on Rights Issue ApprovalINR 496 per share
Dilution Factor (X) 1.33
Fair Value After Dilution at Prevailing PriceINR 465.75 per share

Solara Active Pharma Financial Performance

 FY 2021FY 2022FY 2023
Revenue1,616.881,268.341,443.81
Expenses1,316.021,266.751,399.83
Operating Margin (%)25.597.5410.82
Net Income220.96(58.56)(22.21)
ROCE (%)15.0(0)2.0
Figures in INR Crores unless specified otherwise

Solara Active Pharma Rights Offer Objectives

The net proceeds from the offer are proposed to be used for


Solara Active Pharma Rights Offer Documents


Solara Active Pharma Rights Issue Dates

Rights Issue Approval Date9 May 2024
Rights Issue Record Date15 May 2024
Credit of Rights EntitlementComing soon
Rights Issue Opening Date28 May 2024
Last Date for Market Renunciation5 June 2024
Rights Issue Closing Date11 June 2024
Finalization of Basis of AllotmentComing soon
Rights Allotment DateComing soon
Credit Date Coming soon
Listing DateComing soon

Solara Active Pharma Rights Offer Lead Manager

Coming soon


Solara Active Pharma Rights Offer Registrar

Coming soon


Solara Active Pharma Contact Details

SOLARA ACTIVE PHARMA SCIENCES LIMITED
2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road,
Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127
Phone: +91 44 43446700
Email: 
[email protected]
Website:
www.solara.co.in


Solara Active Pharma Rights Offer FAQs

What is the Solara Active Pharma Rights Issue Price?

The issue price is INR 375 per share.

What is the Solara Active Pharma Rights Issue entitlement ratio?

The eligible shareholders are offered 1 Equity Share for every 3 Equity Share held on the record date.

What is the Solara Active Pharma Rights Issue Record Date?

The Record date is 15 May 2024.

How to Apply for Solara Active Pharma Rights Offer?

The best way to apply for Solara Active Pharma Rights Offer is through Internet banking ASBA. You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an application Form form and deposit the same to your broker.

LEAVE A REPLY

Please enter your comment!
Please enter your name here